(19)
(11)EP 3 761 810 A1

(12)

(43)Date of publication:
13.01.2021 Bulletin 2021/02

(21)Application number: 19714327.4

(22)Date of filing:  07.03.2019
(51)International Patent Classification (IPC): 
A23P 10/30(2016.01)
A23L 33/19(2016.01)
A61K 9/14(2006.01)
A23L 33/185(2016.01)
A23L 33/125(2016.01)
(86)International application number:
PCT/EP2019/055792
(87)International publication number:
WO 2019/170840 (12.09.2019 Gazette  2019/37)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30)Priority: 07.03.2018 EP 18160601

(71)Applicant: Anabio Technologies Limited
Carrigtwohill, Co. Cork T45 RW24 (IE)

(72)Inventors:
  • BLEIEL, Sinead
    Dublin, 4 (IE)
  • KENT, Robert
    Cork (IE)
  • DOCHERTY, Neil Gerard
    Dublin, 16 (IE)
  • WYNAND LE ROUX, Carel
    Dublin (IE)

(74)Representative: Purdylucey Intellectual Property 
6-7 Harcourt Terrace
D02 FH73 Dublin 2
D02 FH73 Dublin 2 (IE)

  


(54)A COMPOSITION FOR TYPE II DIABETICS AND FOR USE IN PROVIDING SUSTAINED ENERGY RELEASE OVER TIME